Factors affecting survival and long-term outcome in the cirrhotic patient undergoing hepatic resection for hepatocellular carcinoma

被引:31
作者
Chiappa, A
Zbar, AP
Audisio, RA
Leone, BE
Biella, F
Staudacher, C
机构
[1] Univ Milan, Dept Gen Surg, European Inst Oncol, I-21100 Milan, Italy
[2] St James Univ Hosp, Leeds, W Yorkshire, England
[3] Whiston Hosp, Div Gen Surg, Prescot, Merseyside, England
[4] Univ Milan, San Raffaele Sci Inst, Dept Emergency Surg, I-21100 Milan, Italy
[5] Univ Milan, San Raffaele Sci Inst, Dept Pathol, I-21100 Milan, Italy
来源
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY | 2000年 / 26卷 / 04期
关键词
cirrhosis; hepatocellular carcinoma; hepatic resections; survival; disease-free survival; prognostic factors;
D O I
10.1053/ejso.1999.0904
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aims: Prognostic analysis of hepatocellular carcinoma (HCC) in the cirrhotic patient undergoing hepatic resection is necessary in order to determine the clinical effect of hepatectomy on prognosis. Patients and methods: Univariate and multivariate retrospective analyses were performed in 51 cirrhotic patients (38 men, 13 women; mean age 65 years, range 43-81 years) with supervening HCC undergoing hepatic resection between January 1993 and December 1997. Results: Segmental liver resection was performed in 39 patients (76%) with non-anatomical (wedge) resections in the remainder of cases;The post-operative mortality rate was 8%. The tumours recurred in 23 patients (45%), with 12 patients (52% of recurrences) recurring within 1 year of surgery and 22 patients (96% of recurrences) within 3 years. Recurrent disease was most frequently intrahepatic (22 patients). Significant risk factors for recurrence were micro/ macro vascular invasion, and symptoms. Conclusions: The recurrence rate of hepatocellular carcinoma in patients with cirrhosis undergoing surgical resection alone is high and actuarial survival at 4 years is low. Other approaches to the treatment of hepatocellular carcinoma in patients with cirrhosis require consideration. (C) 2000 Harcourt Publishers Ltd.
引用
收藏
页码:387 / 392
页数:6
相关论文
共 49 条
[1]  
Adachi E, 1996, CANCER, V77, P2022, DOI 10.1002/(SICI)1097-0142(19960515)77:10<2022::AID-CNCR9>3.0.CO
[2]  
2-S
[3]  
[Anonymous], 1990, ANN SURG, V211, P277
[4]   INTRAHEPATIC RECURRENCE AFTER RESECTION OF HEPATOCELLULAR-CARCINOMA COMPLICATING CIRRHOSIS [J].
BELGHITI, J ;
PANIS, Y ;
FARGES, O ;
BENHAMOU, JP ;
FEKETE, F .
ANNALS OF SURGERY, 1991, 214 (02) :114-117
[5]   THE USE OF OPERATIVE ULTRASOUND IN SURGERY OF PRIMARY LIVER-TUMORS [J].
BISMUTH, H ;
CASTAING, D ;
GARDEN, OJ .
WORLD JOURNAL OF SURGERY, 1987, 11 (05) :610-614
[6]   SURGICAL-TREATMENT OF HEPATOCELLULAR CARCINOMAS IN NONCIRRHOTIC LIVER - EXPERIENCE WITH 68 LIVER RESECTIONS [J].
BISMUTH, H ;
CHICHE, L ;
CASTAING, D .
WORLD JOURNAL OF SURGERY, 1995, 19 (01) :35-41
[7]   LIVER RESECTION VERSUS TRANSPLANTATION FOR HEPATOCELLULAR-CARCINOMA IN CIRRHOTIC-PATIENTS [J].
BISMUTH, H ;
CHICHE, L ;
ADAM, R ;
CASTAING, D ;
DIAMOND, T ;
DENNISON, A .
ANNALS OF SURGERY, 1993, 218 (02) :145-151
[8]  
CHEN MF, 1989, ARCH SURG-CHICAGO, V124, P1025
[9]  
COX DR, 1972, J R STAT SOC B, V34, P187
[10]  
EDMONDSON HA, 1954, CANCER-AM CANCER SOC, V7, P462, DOI 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO